185 related articles for article (PubMed ID: 19026495)
1. Gene expression profile in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.
Alonso V; Neves AF; Marangoni K; Faria PC; Freschi AP; Capaneli AC; Meola J; Goulart LR
Cancer Detect Prev; 2009; 32(4):336-7. PubMed ID: 19026495
[TBL] [Abstract][Full Text] [Related]
2. [Differentially expressed genes in prostate cancer and benign prostatic hyperplasia].
Zhang T; Xu Y; Tang H; Liu M; Ren D; Niu Y
Zhonghua Nan Ke Xue; 2004 Dec; 10(12):897-9. PubMed ID: 15638016
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients.
Faria PC; Saba K; Neves AF; Cordeiro ER; Marangoni K; Freitas DG; Goulart LR
Cancer Invest; 2007 Dec; 25(8):726-32. PubMed ID: 18058470
[TBL] [Abstract][Full Text] [Related]
4. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.
Luo J; Duggan DJ; Chen Y; Sauvageot J; Ewing CM; Bittner ML; Trent JM; Isaacs WB
Cancer Res; 2001 Jun; 61(12):4683-8. PubMed ID: 11406537
[TBL] [Abstract][Full Text] [Related]
5. The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.
Marangoni K; Neves AF; Cardoso AM; Santos WK; Faria PC; Goulart LR
Cancer Detect Prev; 2006; 30(1):7-13. PubMed ID: 16458450
[TBL] [Abstract][Full Text] [Related]
6. The -786T>C promoter polymorphism of the NOS3 gene is associated with prostate cancer progression.
Marangoni K; Araújo TG; Neves AF; Goulart LR
BMC Cancer; 2008 Sep; 8():273. PubMed ID: 18823560
[TBL] [Abstract][Full Text] [Related]
7. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
8. High expression of indoleamine 2,3-dioxygenase gene in prostate cancer.
Feder-Mengus C; Wyler S; Hudolin T; Ruszat R; Bubendorf L; Chiarugi A; Pittelli M; Weber WP; Bachmann A; Gasser TC; Sulser T; Heberer M; Spagnoli GC; Provenzano M
Eur J Cancer; 2008 Oct; 44(15):2266-75. PubMed ID: 18619832
[TBL] [Abstract][Full Text] [Related]
9. DD3(PCA3) gene expression in cancer and prostatic hyperplasia.
Floriano-Sánchez E; Cárdenas-Rodríguez N; Castro-Marín M; Alvarez-Grave P; Lara-Padilla E
Clin Invest Med; 2009 Dec; 32(6):E258. PubMed ID: 20003831
[TBL] [Abstract][Full Text] [Related]
10. Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer.
Rose A; Xu Y; Chen Z; Fan Z; Stamey TA; McNeal JE; Caldwell M; Peehl DM
Cancer Lett; 2005 Sep; 227(2):213-22. PubMed ID: 16112424
[TBL] [Abstract][Full Text] [Related]
11. Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis.
Neves AF; Araújo TG; Biase WK; Meola J; Alcântara TM; Freitas DG; Goulart LR
Clin Biochem; 2008 Oct; 41(14-15):1191-8. PubMed ID: 18640109
[TBL] [Abstract][Full Text] [Related]
12. Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma.
Luo J; Dunn TA; Ewing CM; Walsh PC; Isaacs WB
Prostate; 2003 Oct; 57(2):134-9. PubMed ID: 12949937
[TBL] [Abstract][Full Text] [Related]
13. Different basal expression of type T1 and T2 cytokines in peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate.
Elsässer-Beile U; Gierschner D; Jantscheff P; Schultze-Seemann W; Katzenwadel A; Wetterauer U
Anticancer Res; 2003; 23(5A):4027-31. PubMed ID: 14666714
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
Avgeris M; Koutalellis G; Fragoulis EG; Scorilas A
Clin Biochem; 2008 Oct; 41(14-15):1140-9. PubMed ID: 18586020
[TBL] [Abstract][Full Text] [Related]
15. Comparison of genetic alterations detected in circulating microsatellite DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia.
Müller I; Urban K; Pantel K; Schwarzenbach H
Ann N Y Acad Sci; 2006 Sep; 1075():222-9. PubMed ID: 17108215
[TBL] [Abstract][Full Text] [Related]
16. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
[TBL] [Abstract][Full Text] [Related]
17. [Serum cytokine profiling of prostate cancer and benign prostatic hyperplasia using recombinant antibody microarray].
Zhang L; Sun SK; Shi LX; Zhang X
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):584-8. PubMed ID: 20873589
[TBL] [Abstract][Full Text] [Related]
18. Detection of differentially expressed genes in prostate cancer by combining suppression subtractive hybridization and cDNA library array.
Porkka KP; Visakorpi T
J Pathol; 2001 Jan; 193(1):73-9. PubMed ID: 11169518
[TBL] [Abstract][Full Text] [Related]
19. [Expression of different genes in transitional zone and peripheral zone of human normal prostate].
Sun HB; Xia SJ; Tang XD
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):610-3. PubMed ID: 15949358
[TBL] [Abstract][Full Text] [Related]
20. [Quantitative detection of differential display code 3 mRNA in peripheral blood of patients with prostate cancer].
Weng ZL; Yu KY; Mao XL; Tao ZH; Chen XD; Wu XL; Hu YP; Wang SQ; Li CD; Chen ZG
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(41):2911-5. PubMed ID: 17288789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
